Article
Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.
Tuberculosis (Edinburgh, Scotland) - 1 Jan 2014
Pholwat Suporn, Stroup Suzanne, Gratz Jean, Trangan Varittha, Foongladda Suporn, Kumburu Happiness, Juma Saumu Pazia, Kibiki Gibson, Houpt Eric
Abstract excerpt
Pyrazinamide (PZA) plays the important role in shortening the tuberculosis treatment period and in treating MDR-TB. Phenotypic PZA susceptibility methods are limited because they require specialized acidified media, which increases costs and complexity. In this study we developed a genotypic high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
